v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (2,242,721) $ (1,784,082)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 2,922,967 2,742,229
Amortization of debt issuance costs 71,037 71,050
Stock based compensation expense related to issuance of restricted stock 8,071 8,008
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:    
Other assets 385,505 480,198
Accounts payable and accrued liabilities 1,226,223 77,546
Due to affiliates (41,318) 566,141
Net cash provided by operating activities 2,329,764 2,161,090
Cash flows from investing activities:    
Additions to real estate (1,158,619) (1,735,328)
Purchase of short-term U.S. Treasury Securities (2,703,754)
Maturity of short-term U.S. Treasury Securities 8,161,459
Net cash provided by (used in) investing activities 4,299,086 (1,735,328)
Cash flows from financing activities:    
Scheduled principal payments of mortgage loans (966,646) (920,043)
Net cash used in financing activities (966,646) (920,043)
Net change in cash, cash equivalents, and restricted cash 5,662,204 (494,281)
Cash, cash equivalents, and restricted cash, beginning of period 4,248,386 11,976,151
Cash, cash equivalents, and restricted cash, end of period 9,910,590 11,481,870
Supplemental disclosures and non-cash transactions:    
Cash paid for interest 2,557,843 2,604,378
Distributions payable to preferred unit holders in our operating partnership $ 780,572 $ 738,598